These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 29499287

  • 21. Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification.
    Verbruggen G, Wittoek R, Vander Cruyssen B, Elewaut D.
    Ann Rheum Dis; 2012 Jun; 71(6):891-8. PubMed ID: 22128078
    [Abstract] [Full Text] [Related]

  • 22. Course of Magnetic Resonance Imaging-Detected Inflammation and Structural Lesions in the Sacroiliac Joints of Patients in the Randomized, Double-Blind, Placebo-Controlled Danish Multicenter Study of Adalimumab in Spondyloarthritis, as Assessed by the Berlin and Spondyloarthritis Research Consortium of Canada Methods.
    Pedersen SJ, Poddubnyy D, Sørensen IJ, Loft AG, Hindrup JS, Thamsborg G, Asmussen K, Hendricks O, Nørregaard J, Piil AD, Møller JM, Jurik AG, Balding L, Lambert RG, Sieper J, Østergaard M.
    Arthritis Rheumatol; 2016 Feb; 68(2):418-29. PubMed ID: 26414004
    [Abstract] [Full Text] [Related]

  • 23. A prospective, randomized, double-blind, multicentre, parallel-group, active controlled study to compare efficacy and safety of biosimilar adalimumab (Exemptia; ZRC-3197) and adalimumab (Humira) in patients with rheumatoid arthritis.
    Jani RH, Gupta R, Bhatia G, Rathi G, Ashok Kumar P, Sharma R, Kumar U, Gauri LA, Jadhav P, Bartakke G, Haridas V, Jain D, Mendiratta SK.
    Int J Rheum Dis; 2016 Nov; 19(11):1157-1168. PubMed ID: 26176644
    [Abstract] [Full Text] [Related]

  • 24. Assessment of structural lesions, synovitis and bone marrow lesions in erosive hand osteoarthritis on MRI (0.3T) compared to the radiographic anatomical Verbruggen-Veys score.
    Allado E, Wittoek R, Ferrero S, Albuisson E, Chary-Valckenaere I, Roux C, Loeuille D.
    PLoS One; 2020 Nov; 15(6):e0234972. PubMed ID: 32574222
    [Abstract] [Full Text] [Related]

  • 25. Increasing synovitis and bone marrow lesions are associated with incident joint tenderness in hand osteoarthritis.
    Haugen IK, Slatkowsky Christensen B, Bøyesen P, Sesseng S, van der Heijde D, Kvien TK.
    Ann Rheum Dis; 2016 Apr; 75(4):702-8. PubMed ID: 25755139
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A recently developed MRI scoring system for hand osteoarthritis: its application in a clinical setting.
    Ramonda R, Favero M, Vio S, Lacognata C, Frallonardo P, Belluzzi E, Campana C, Lorenzin M, Ortolan A, Angelini F, Piccoli A, Oliviero F, Punzi L.
    Clin Rheumatol; 2016 Aug; 35(8):2079-2086. PubMed ID: 27236512
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1.
    Mease PJ, van der Heijde D, Ritchlin CT, Okada M, Cuchacovich RS, Shuler CL, Lin CY, Braun DK, Lee CH, Gladman DD, SPIRIT-P1 Study Group.
    Ann Rheum Dis; 2017 Jan; 76(1):79-87. PubMed ID: 27553214
    [Abstract] [Full Text] [Related]

  • 31. Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study-a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial.
    Kedor C, Detert J, Rau R, Wassenberg S, Listing J, Klaus P, Braun T, Hermann W, Weiner SM, Buttgereit F, Burmester GR.
    RMD Open; 2021 Jul; 7(2):. PubMed ID: 34215704
    [Abstract] [Full Text] [Related]

  • 32. Methotrexate to treat hand osteoarthritis with synovitis (METHODS): an Australian, multisite, parallel-group, double-blind, randomised, placebo-controlled trial.
    Wang Y, Jones G, Keen HI, Hill CL, Wluka AE, Kasza J, Teichtahl AJ, Antony B, O'Sullivan R, Cicuttini FM.
    Lancet; 2023 Nov 11; 402(10414):1764-1772. PubMed ID: 37839420
    [Abstract] [Full Text] [Related]

  • 33. METHODS - A randomised controlled trial of METhotrexate to treat Hand Osteoarthritis with Synovitis: study protocol for a randomised controlled trial.
    Wang Y, Teichtahl AJ, Jones G, Keen HI, Hill CL, Wluka AE, Kasza J, Cicuttini FM.
    BMC Musculoskelet Disord; 2021 Nov 15; 22(1):953. PubMed ID: 34781952
    [Abstract] [Full Text] [Related]

  • 34. Magnetic resonance therapy for knee osteoarthritis: a randomized, double blind placebo controlled trial.
    Gökşen N, Çaliş M, Doğan S, Çaliş HT, Özgöçmen S.
    Eur J Phys Rehabil Med; 2016 Aug 15; 52(4):431-9. PubMed ID: 26799573
    [Abstract] [Full Text] [Related]

  • 35. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A, Ma C, Ahdieh H, Galer BS.
    Clin Ther; 2006 Mar 15; 28(3):352-64. PubMed ID: 16750450
    [Abstract] [Full Text] [Related]

  • 36. Efficacy and Tolerability of GCSB-5 for Hand Osteoarthritis: A Randomized, Controlled Trial.
    Park JK, Shin K, Kang EH, Ha YJ, Lee YJ, Lee KH, Lee EY, Song YW, Choi Y, Lee EB.
    Clin Ther; 2016 Aug 15; 38(8):1858-1868.e2. PubMed ID: 27449412
    [Abstract] [Full Text] [Related]

  • 37. Hydroxychloroquine effectiveness in reducing symptoms of hand osteoarthritis (HERO): study protocol for a randomized controlled trial.
    Kingsbury SR, Tharmanathan P, Adamson J, Arden NK, Birrell F, Cockayne S, Dickson J, Doherty M, Dziedzic KS, Grainger A, Hewitt CE, O'Neill TW, Scott DL, Vincent TL, Wakefield RJ, Watt FE, Torgerson DJ, Conaghan PG.
    Trials; 2013 Mar 02; 14():64. PubMed ID: 23452375
    [Abstract] [Full Text] [Related]

  • 38. Effects of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial.
    Petrella RJ, DiSilvestro MD, Hildebrand C.
    Arch Intern Med; 2002 Feb 11; 162(3):292-8. PubMed ID: 11822921
    [Abstract] [Full Text] [Related]

  • 39. Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study.
    Weisman MH, Moreland LW, Furst DE, Weinblatt ME, Keystone EC, Paulus HE, Teoh LS, Velagapudi RB, Noertersheuser PA, Granneman GR, Fischkoff SA, Chartash EK.
    Clin Ther; 2003 Jun 11; 25(6):1700-21. PubMed ID: 12860493
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.